1. Home
  2. CHGG vs BHST Comparison

CHGG vs BHST Comparison

Compare CHGG & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chegg Inc.

CHGG

Chegg Inc.

HOLD

Current Price

$1.03

Market Cap

117.4M

Sector

Real Estate

ML Signal

HOLD

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

HOLD

Current Price

$4.00

Market Cap

97.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHGG
BHST
Founded
2005
2007
Country
United States
Canada
Employees
N/A
87
Industry
Other Consumer Services
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
117.4M
97.7M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
CHGG
BHST
Price
$1.03
$4.00
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
2.4M
36.2K
Earning Date
05-06-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
88.15
N/A
EPS
N/A
N/A
Revenue
$376,908,000.00
N/A
Revenue This Year
N/A
$146.27
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$3.57
52 Week High
$1.89
$12.80

Technical Indicators

Market Signals
Indicator
CHGG
BHST
Relative Strength Index (RSI) 50.21 42.59
Support Level $0.87 $3.57
Resistance Level $1.26 $4.54
Average True Range (ATR) 0.13 0.24
MACD -0.03 -0.00
Stochastic Oscillator 26.57 48.04

Price Performance

Historical Comparison
CHGG
BHST

About CHGG Chegg Inc.

Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Chegg Skilling; and Academic Services, which derives maximum revenue. Geographically, it derives in United States and International.

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: